133 related articles for article (PubMed ID: 36722791)
1. Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy.
Lontos K; Tsagianni A; Agha M; Raptis A; Hou JZ; Farah R; Redner RL; Im A; Dorritie KA; Sehgal A; Rossetti J; Aggarwal N; Saul M; Boyiadzis M; Bailey NG
Leuk Lymphoma; 2023 Mar; 64(3):750-752. PubMed ID: 36722791
[No Abstract] [Full Text] [Related]
2. CD34 immunohistochemistry in bone marrow biopsies for early response assessment in acute myeloid leukemia.
Jain S; Mahapatra M; Pati HP
Int J Lab Hematol; 2015 Dec; 37(6):746-51. PubMed ID: 26248894
[TBL] [Abstract][Full Text] [Related]
3. [Ratio of Primary Bone Marrow Cells after Induction Chemothrapy for Two Weeks in the Patients with Ph
Wu XF; Sun L; Li TT; Yin XC; Ran XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):749-753. PubMed ID: 28641629
[TBL] [Abstract][Full Text] [Related]
4. Remission induction chemotherapy induces in vivo caspase-dependent apoptosis in bone marrow acute myeloid leukemia blast cells and spares lymphocytes.
Vial JP; Tabrizi R; Pigneux A; Lacombe F; Praloran V; Belloc F
Cytometry B Clin Cytom; 2006 May; 70(3):115-23. PubMed ID: 16572429
[TBL] [Abstract][Full Text] [Related]
5. Is the D14 bone marrow in acute myeloid leukemia still the gold standard?
Ofran Y
Curr Opin Hematol; 2016 Mar; 23(2):108-14. PubMed ID: 26717195
[TBL] [Abstract][Full Text] [Related]
6. Blast Percentage of Bone Marrow Aspirate on Day 14 of Induction Chemotherapy Predicts Adult Acute Lymphoblastic Leukemia Treatment Outcomes.
Park HS; Kim DY; Choi EJ; Lee JH; Lee JH; Jeon M; Kang YA; Lee YS; Seol M; Cho YU; Jang S; Chi HS; Lee KH; Park CJ
Acta Haematol; 2018; 139(4):220-227. PubMed ID: 29860259
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Short NJ; Kantarjian HM; Sasaki K; Cortes JE; Ravandi F; Thomas DA; Garcia-Manero G; Khouri I; Kebriaei P; Champlin RE; Pierce S; Issa GC; Konopleva M; Kadia TM; Bueso-Ramos C; Khoury JD; Jain N; O'Brien SM; Jabbour E
Cancer; 2016 Dec; 122(24):3812-3820. PubMed ID: 27508525
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of early treatment response in children with acute myeloid leukemia].
Tie LJ; Gu LJ; Song DL; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Chen J; Wang YP; Zou JY
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1837-40. PubMed ID: 17054861
[TBL] [Abstract][Full Text] [Related]
9. Analysis of clinical profile and role of various prognostic factors in early bone marrow response in children with acute lymphoblastic leukemia treated by Modified Multicenter Protocol (MCP) 841 protocol: Experience from a tertiary care center in North India.
Garg M; Abrol P; Gupta N; Bharti S; Nadda A
Indian J Cancer; 2023 Oct; 60(4):521-527. PubMed ID: 38258870
[TBL] [Abstract][Full Text] [Related]
10. Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses.
Loken MR; Chu SC; Fritschle W; Kalnoski M; Wells DA
Cytometry B Clin Cytom; 2009 Jan; 76(1):27-36. PubMed ID: 18548614
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of blast percentage assessed by bone marrow trephine biopsy and aspirate smear of myeloid malignancies.
Yang CF; Gau JP; Hsiao LT; Hsu CY
Pathology; 2021 Oct; 53(6):740-745. PubMed ID: 33745704
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of reproducible immunophenotypic markers of marrow dysplasia.
Della Porta MG; Picone C; Tenore A; Yokose N; Malcovati L; Cazzola M; Ogata K
Haematologica; 2014 Jan; 99(1):e8-10. PubMed ID: 24425693
[No Abstract] [Full Text] [Related]
13. Clinical Significance of Bone Marrow Involvement as Confirmed by Bone Marrow Aspiration vs. Bone Marrow Biopsy in Diffuse Large B-cell Lymphoma.
Hantaweepant C; Chinthammitr Y; Khuhapinant A; Sukpanichnant S
J Med Assoc Thai; 2016 Mar; 99(3):262-9. PubMed ID: 27276736
[TBL] [Abstract][Full Text] [Related]
14. Blasts-more than meets the eye: evaluation of post-induction day 21 bone marrow in CBFB rearranged acute leukemia.
Xu X; Duncavage EJ
Int J Clin Exp Pathol; 2014; 7(7):4498-502. PubMed ID: 25120841
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow biopsy during induction chemotherapy for acute myeloid leukaemia identifies only 50% of patients with resistant disease.
Roberts MM; Juttner CA; To LB; Kimber RJ
Leuk Res; 1988; 12(10):817-21. PubMed ID: 3199841
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of blood and marrow findings in acute myelogenous leukemia in remission. A Southeastern Cancer Study Group report.
Vogler WR; Raney MR
Cancer; 1988 Jun; 61(12):2481-6. PubMed ID: 3163256
[TBL] [Abstract][Full Text] [Related]
17. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow leukemic progenitor cell content in pediatric T-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse.
Uckun FM; Gaynon PS; Stram DO; Sensel MG; Sarquis MB; Willoughby M
Leuk Lymphoma; 2001 Jan; 40(3-4):279-85. PubMed ID: 11426549
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow biopsy in adult acute lymphoblastic leukemia: morphological characteristics and contribution to the study of prognostic factors.
Thomas X; Le QH; Danaïla C; Lhéritier V; Ffrench M
Leuk Res; 2002 Oct; 26(10):909-18. PubMed ID: 12163052
[TBL] [Abstract][Full Text] [Related]
20. Comparison between 1-needle technique versus 2-needle technique for bone marrow aspiration and biopsy procedures.
Al-Ibraheemi A; Pham T; Chen L; Syklawer E; Quesada A; Wahed A; Nedelcu E; Nguyen AN
Arch Pathol Lab Med; 2013 Jul; 137(7):974-8. PubMed ID: 23808470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]